Background: This study will systematically evaluate the psychological effects of advanced care (AC) on patients who received endoscopic gastric cancer resection (EGCR).
Introduction
Gastric cancer (GC) is one of the most common cancers around the world. [1] [2] [3] It is often characterized as indigestion and stomach discomfort, a bloated feeling after eating, mild nausea, loss of appetite, and heartburn at the early stage. [4] [5] [6] At the advanced stage, it manifests as blood in the stool, vomiting, weight loss for no known reason, stomach pain, jaundice, ascites, and trouble swallowing. [7] [8] [9] It has been reported that >951,000 people have been diagnosed as GC annually as new cases, and about 723,000 died from such disease. [10, 11] Surgical resection of GC, especially for endoscopic gastric cancer resection (EGCR), is widely used to manage GC. [12] [13] [14] [15] [16] [17] [18] Previous studies found that patients with GC who received EGCR often have psychological disorders. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Although numerous studies reported that advanced care (AC) can help relieve psychological disorders in GC patients who received EGCR. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] However, no evidence on levels of evidence-based medicine is provided. Therefore, in this study, we will systematically assess the psychological effects of AC on patients who underwent EGCR.
Methods

2.1.
Criteria for considering studies for this study 2.1.1. Study types. We will consider randomized controlled trials (RCTs) that assess the psychological effects of AC in patients received EGCR. All non-RCTs, such as animal studies, case studies, observational studies will be excluded.
Participant types.
People of any age, in any setting who are diagnosed as EGCR, will be included in this study. The secondary outcomes consist of anxiety and health-related quality of life. Anxiety is assessed via Hamilton Anxiety Rating Scale or other tools. Health-related quality of life is evaluated by any relevant scales, including 36-Item Short Form Health Survey. In addition, adverse events will also be assessed.
Search methods
Literature Database, and China National Knowledge Infrastructure from inception to the present with no language limitation. In addition, gray literature will also be searched, such as conference proceedings, dissertations, and reference lists of associated reviews. The detailed search strategy for Cochrane Library is showed in Table 1 . We will utilize the similar search strategy to other electronic databases.
2.3. Data collection 2.3.1. Study selection. Two authors will independently screen all titles and abstracts retrieved to check whether they meet inclusion criteria. We will obtain full papers of the remaining papers for judging their eligibility criteria. Any divergences between 2 authors will be solved with a third author to make a consensus decision by discussion. The results of study selection will be showed in a flowchart of based on the guideline of Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
2.3.2. Data extraction. Two authors will independently extract data from all eligible studies using a data extraction form. Any disagreements will be solved by another author through discussion. Specifically, the following information will be extracted: 2.3.3. Missing data management. If essential data are missing or insufficient, we will obtain them from primary authors using email. We will analyze available data if we can not obtain these data.
Risk of bias evaluation
Independently, 2 authors will evaluate the risk of bias of eligible studies using Cochrane Risk of Bias Tool. We will invite a third author to solve any divisions between 2 authors. In addition, we will exert our evaluation of risk of bias using "Risk of bias" summary figures.
Measures of treatment effect
For continuous outcome values, mean difference or standardized mean difference will be calculated with 95% confidence intervals. For dichotomous outcome values, risk ratio will be calculated with 95% confidence intervals.
Assessment of heterogeneity
Clinical heterogeneity will be evaluated using I 2 test. Where I 2 values are 50%, heterogeneity is considered as low, and a fixedeffects model will be used. Where I 2 values exceed 50%, heterogeneity is regarded as significant, and a random-effects model will be utilized.
Data synthesis and analysis
RevMan 5.3 software is utilized to perform statistical analysis. We will pool the data where the I 2 values are 50%, and meta-analysis will be carried out. We will not pool the data where the I 2 values are >50%, and subgroup analysis will be performed. We will report narrative summary and will not include any meta-analysis if there is still significant heterogeneity after subgroup analysis.
Additional analysis
If substantial heterogeneity exists among eligible studies, we will conduct subgroup analysis to investigate reasons for heterogeneity based on the different study quality, treatments, and outcome measurements.
Additionally, sensitivity analysis will be carried out to identify the robustness of pooled outcome results by removing high risk of bias studies. Table 1 Search strategy utilized for Cochrane Library.
Number
Search terms We will perform Funnel plot [33] and Egger regression test [34] to check reporting bias when sufficient studies are included.
Ethics and dissemination
No ethical approval is inquired because this study will only analyze previously published data. We will publish this study at a peer-reviewed journal.
Discussion
GC is one of the most common cancers globally, which leads to high mortality. [1, 2] Although EGCR is often widely utilized to treat such disorder effectively, most patients experience psychological disorders. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Previous studies have reported that AC can benefit GC patients who received EGCR. However, its results are still inconsistent on the levels of evidence-based medicine. Therefore, this study will assess the psychological effects of AC on the GC patients who undergo EGCR. The results of this study may summarize the evidence of AC for psychological outcomes in GC patients received EGCR across all published RCTs.
